(CEPO) Cantor Equity Partners I - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: (N/A)

Financial Services, Healthcare, Real Estate, Technology, Software

CEPO EPS (Earnings per Share)

EPS (Earnings per Share) of CEPO over the last years for every Quarter: "2023-12": null, "2024-03": -0, "2024-06": null, "2024-09": null, "2024-12": null, "2025-03": 0,

CEPO Revenue

Revenue of CEPO over the last years for every Quarter: 2023-12: 0, 2024-03: null, 2024-06: 0, 2024-09: 0, 2024-12: 0, 2025-03: 0,

Description: CEPO Cantor Equity Partners I

Cantor Equity Partners I, Inc. is a shell company with no significant operations, formed with the intention of executing a business combination with a target company. The companys focus is on identifying potential targets in the financial services, healthcare, real estate services, technology, and software industries.

From a trading perspective, key performance indicators (KPIs) to monitor for CEPO include trading volume, liquidity, and volatility. Given the companys blank-check nature, its stock price is likely to be influenced by market sentiment and speculation about potential merger targets. Other relevant KPIs include the companys cash per share, which is crucial in determining its ability to complete a business combination, and the number of days until the companys funds are expected to be depleted, which could impact the urgency of finding a suitable target.

To evaluate the potential success of CEPOs business combination, its essential to assess the management teams track record, the companys search criteria, and the competitive landscape of potential target industries. Key metrics to monitor include the time-to-combination, deal size, and the target companys growth prospects, profitability, and competitive positioning.

Investors in CEPO should be aware of the risks associated with blank-check companies, including the potential for failed combinations, dilution, and loss of investment. To mitigate these risks, its crucial to closely monitor the companys announcements, regulatory filings, and industry trends. By analyzing these factors, investors can make more informed decisions about their investment in CEPO.

Additional Sources for CEPO Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CEPO Stock Overview

Market Cap in USD 208m
Sector Financial Services
Industry Shell Companies
IPO / Inception 2025-01-07

CEPO Stock Ratings

Growth Rating 44.3
Fundamental -23.5
Dividend Rating 0.0
Rel. Strength 29.9
Analysts -
Fair Price Momentum 14.67 USD
Fair Price DCF -

CEPO Dividends

Currently no dividends paid

CEPO Growth Ratios

Growth Correlation 3m 37.4%
Growth Correlation 12m 91.9%
Growth Correlation 5y 91.9%
CAGR 5y 42.09%
CAGR/Max DD 5y 3.96
Sharpe Ratio 12m -0.15
Alpha 37.78
Beta 0.011
Volatility 184.57%
Current Volume 6967.3k
Average Volume 20d 201.1k
Stop Loss 13.8 (-3.4%)
What is the price of CEPO shares?
As of July 18, 2025, the stock is trading at USD 14.28 with a total of 6,967,321 shares traded.
Over the past week, the price has changed by +21.33%, over one month by +15.91%, over three months by +37.97% and over the past year by +42.09%.
Is Cantor Equity Partners I a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Cantor Equity Partners I is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -23.45 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CEPO is around 14.67 USD . This means that CEPO is currently overvalued and has a potential downside of 2.73%.
Is CEPO a buy, sell or hold?
Cantor Equity Partners I has no consensus analysts rating.
What are the forecasts for CEPO share price target?
According to our own proprietary Forecast Model, CEPO Cantor Equity Partners I will be worth about 15.8 in July 2026. The stock is currently trading at 14.28. This means that the stock has a potential upside of +10.92%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 15.8 10.9%